Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
about
Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.Biomarkers for amyotrophic lateral sclerosis.A generic research paradigm for identification and validation of early molecular diagnostics and new therapeutics in common disorders.Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.
P2860
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@ast
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@en
type
label
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@ast
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@en
prefLabel
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@ast
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@en
P2093
P2860
P356
P1476
Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
@en
P2093
Dietrich A Stephan
Keith D Coon
Travis Dunckley
P2860
P304
P356
10.1586/14737159.4.3.361
P577
2004-05-01T00:00:00Z